Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Medical College of Wisconsin
Merck Sharp & Dohme LLC
University of Kentucky
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
University of Michigan Rogel Cancer Center
University of Texas Southwestern Medical Center
University of California, San Diego
Mayo Clinic
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
University of Michigan Rogel Cancer Center
Radiation Therapy Oncology Group
University of Pittsburgh
Merck Sharp & Dohme LLC
Incyte Corporation
Wake Forest University Health Sciences
Washington University School of Medicine
Medical University of South Carolina
Dana-Farber Cancer Institute
University of Southern California
Hoffmann-La Roche
University of Arkansas
Calliditas Therapeutics AB
Incyte Corporation
GERCOR - Multidisciplinary Oncology Cooperative Group
University of California, San Diego
Merck Sharp & Dohme LLC
Nektar Therapeutics
NGM Biopharmaceuticals, Inc
M.D. Anderson Cancer Center
University of Chicago
University of Chicago
Thomas Jefferson University
Merck Sharp & Dohme LLC
Medical College of Wisconsin
Bayer
GeoVax, Inc.
West Virginia University
University of Pittsburgh
City of Hope Medical Center
Medical University of South Carolina
Medical University of South Carolina
Medical College of Wisconsin
University of Pittsburgh
Hospital of Stomatology, Wuhan University
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Immutep S.A.S.